Design Therapeutics, Inc.
5 clinical trials · Sponsor
◉ Watch Design Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy (NCT07024693) | Design Therapeutics, Inc. | 2025-07-30 |
| A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia (NCT06874010) | Design Therapeutics, Inc. | 2025-06-01 |
| A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants (NCT06772870) | Design Therapeutics, Inc. | 2025-02-01 |
| Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia (NCT05573698) | Design Therapeutics, Inc. | 2022-09-27 |
| Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia (NCT05285540) | Design Therapeutics, Inc. | 2022-03-11 |
Track Design Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.